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Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) co-infection 
in pregnancy are risk factors that affect both maternal and perinatal 
outcomes. TB is preventable in pregnant women living with HIV by 
initiating Isoniazid (INH) prophylactic therapy (IPT) if there are no TB 
symptoms  upon screening. This study analysed health system factors 
associated with TB screening of pregnant women living with HIV, in 
2011/2012, in antenatal care services in UThungulu District, in the 
Province of KwaZulu-Natal.  
Purpose  
To analyze health system factors associated with TB screening of 
pregnant women living with HIV in Basic Antenatal Care (BANC) 
services in UThungulu District.  
Objectives 
To determine the proportion of pregnant women living with HIV screened 
for TB at initiation of BANC in health facilities in UThungulu District and 
to analyze health system factors associated with the TB screening.  
Methods 
An observational cross-sectional study design, with descriptive and 
analytic components was carried out in health facilities in UThungulu 
District.  Multi-stage sampling was used to select health facilities and 
then to select pregnant women living with HIV initiating BANC. An 
interviewer-administered structured questionnaire and data extraction 
tools were used to collect data. Data was analysed using descriptive and 
analytic statistics using mixed effect logistic regression with cluster 
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effect, and doer and non-doer analysis, with Fischer’s exact analysis.  
The level of statistical significance was set at p=0.05. 
Results  
The results of the study showed that pregnant women living with HIV 
were 3 times more likely to be screened for TB in clinics where 
personnel had been trained on TB management, on Antiretroviral 
Therapy (ART) for pregnant women, and on the Prevention of Mother to 
Child Transmission (PMTCT) of HIV; and in clinics with a full-time 
enrolled nurse.  Furthermore, clinics where ALL pregnant women living 
with HIV were screened for TB were more likely to have: a full-time 
midwife; personnel at all levels trained on TB management, on ART for 
pregnant women, and on PMTCT; and a policy to trace pregnant women 
who do not adhere to their scheduled subsequent visit.  
Conclusion 
Clinics with appropriate, and trained personnel, with a policy to follow-up 
pregnant women who do not adhere to scheduled appointments, are 
health system factors associated with the implementation of the National 
Department of Health Guideline and World Health Organisation 
recommendation for the screening of TB in pregnancy for women living 
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DEFINITION OF TERMS 
 
 Antenatal period shall mean the time from when a woman becomes 
pregnant until she goes into labour to deliver the baby. 
 Basic antenatal care (BANC) shall mean health care provided to 
pregnant women at low risk during the antenatal period.   
 Living with HIV shall mean a person who has tested positive for HIV 
after having had an HIV screening test and an HIV confirmatory test 
on-site, including those pregnant women who already knew their HIV 
status before initiation of BANC. 
 Tuberculosis (TB) shall mean pulmonary tuberculosis. 
 TB screening shall mean both symptomatic screening and 
bacteriological investigations. 
 Barriers shall mean anything that obstructs or restrains progress or 
access to comprehensive BANC.  
 Level one antenatal care service shall mean BANC provided in a 
District Hospital, Community Health Centre (CHC) or Primary Health 
Care (PHC) facility. 
 Essential package of antenatal care service shall mean five 
scheduled visits integrated with Sexually Transmitted Infections (STI) 
prevention, counselling and treatment; onsite screening for syphilis 
and treatment; TB screening; and strategies for Prevention of Mother 
to Child Transmission (PMTCT)  
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CHAPTER 1: INTRODUCTION  
1.1 Background 
Tuberculosis (TB) is a communicable disease of global concern, with the 
greatest burden experienced in low- and middle-income countries [1-6]. 
Globally, gains in controlling the TB epidemic have been observed: between 
2000 and 2015 the number of new TB cases decreased by about 1.5% per 
year, with an estimated 49 million lives saved through TB diagnosis and 
treatment [6-8]. The Global Tuberculosis Report 2016 expressed concern that 
the 1.5% decline needs to be accelerated to at least 4 – 5% by 2020 [8]. The 
progress towards reducing TB incidence has been varied, with some countries 
in the Americas, Western Pacific and East Asia regions showing major decline, 
while other countries in the south Asian and sub-Saharan regions showing a 
slower decline [6, 10]. In 2013, 56% of new TB cases reported were from the 
South East Asia and Western Pacific regions [6], while in 2015, 60% of new TB 
cases were from six (6) countries, that is India, Indonesia, China, Nigeria, 
Pakistan and South Africa [6, 8].   In the south Asian and African regions the 
high TB incidence is associated with a maturing HIV epidemic [6, 8]. Worldwide, 
in 2013, TB in women accounted for about 33% of TB incidence [6, 9] and by 
2015, had increased to 34% [8]. 
Worldwide, a 22% decrease in TB-related deaths was observed between 2000 
and 2015.  However, TB remains a leading cause of death in ten (10) countries, 
that is: India, Indonesia, Nigeria, Pakistan, South Africa, Bangladesh, the 
Democratic Republic of the Congo, China, the United Republic of Tanzania and 
Mozambique [8]. In 2013, South Africa and India accounted for one third of 
global TB-related deaths [6, 10]. TB is a leading cause of death particularly in 
women [4, 6, 10]. In resource-limited settings, including South Africa, women of 
child-bearing age (especially between 15 and 24 years) are disproportionately 
affected by TB because of the high HIV prevalence in this age group [3, 11].  




TB incidence for the pregnant population is not available, but is expected to be 
the same as in the general population [3]. An increase in the incidence of TB in 
the general population may lead to a higher risk of TB among pregnant women 
[3, 11, 12].  Studies have shown that pregnancy alone is not associated with an 
increased risk of TB infection [3, 11]. However, worldwide, TB accounts for 6–
15% of all maternal deaths [13, 14].  In South Africa, in the context of co-
infection with HIV, TB is the third leading non-obstetric cause of maternal 
mortality [3, 14, 15], and in KwaZulu-Natal (KZN) TB is the second highest 
cause of death, accounting for 14% of maternal deaths [11, 15, 16].  
In South Africa, TB prevalence was up to ten times higher in pregnant women 
living with HIV than in pregnant women without HIV infection [6, 17]. The 
relative risk of TB among pregnant women living with HIV, compared to those 
who are HIV uninfected, is 20- to 37-fold, depending on the state of the HIV 
epidemic and the pregnant women’s CD4 cell count [18]. TB and HIV co-
infection in pregnant women is the major non-pregnancy related cause of 
maternal mortality and it increases when direct obstetric causes are excluded 
[13, 19]. Furthermore, TB in pregnant women living with HIV increases the risk 
of vertical transmission of HIV [3, 13, 20, 21].  High child morbidity and mortality 
rates have been attributed to TB in infants, whether acquired during the 
antenatal or postpartum period [2, 7, 18, 22, 23] Furthermore, delayed 
diagnosis of TB and lack of treatment in pregnancy contributes to neonatal TB 
[3, 13, 24, 25].  
Early detection and screening for TB in pregnancy in women living with HIV 
contributes to preventing maternal deaths due to TB, to preventing mother-to-
child transmission of HIV, and to preventing neonatal morbidity and mortality 
due to TB [3, 9, 16, 26]. The World Health Organization (WHO) recommended 
that routine TB symptom-based screening should be implemented with 
pregnant women living with HIV in high HIV prevalence regions, as TB infection 
is high in such settings [3, 27-30]. WHO also recommended that pregnant 
women living with HIV should be systematically screened for active TB at each 
antenatal care visit [9]. The use of a simple screening questionnaire to exclude 
current cough, fever, weight loss, and night sweats should be used at initiation 
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of Basic Antenatal Care (BANC), and at each subsequent visit, to identify 
pregnant women living with HIV eligible for isoniazid preventive therapy (IPT) or 
for further TB investigation [3, 13]. TB is often not detected in pregnancy due to 
lack of symptoms, especially where there is co-infection with HIV, thus the need 
for repeated screening [13, 28, 31] at subsequent antenatal care visits [3, 32]. 
Studies have shown that failure to follow this protocol is a factor associated with 
the delay in the diagnosis of TB, delay in the initiation of treatment, and is 
contributory to TB-related maternal mortality [11, 30]. A study in Soweto, South 
Africa, showed that TB screening, through the use of a limited number of 
questions during routine BANC, was feasible and not time consuming [11].  
1.2 Problem statement 
Inadequate screening for TB during antenatal care in pregnant women living 
with HIV has been identified as one of the contributory factors to high maternal 
mortality due to Non-Pregnancy Related Infections (NPRI) [32-35]. The high 
burden of both HIV and TB in South Africa is expected to raise a clinician’s 
suspicion and motivate the routine screening of all pregnant women for active 
TB, as per National Department of Health guideline and WHO recommendation 
[3]. TB in pregnant women living with HIV is often not detected due to: lack of 
TB suspicion; symptom screening not being offered to all pregnant women due 
to workload concerns by some health workers [12, 33, 34]; few signs or lack of 
symptoms during pregnancy [32, 36]; and/or due to expensive sputum culture 
[37].  
In South Africa, TB screening data for pregnant women, including pregnant 
women living with HIV, is not routinely collected to determine case finding and 
to determine the TB case load in pregnant women [38].  BANC offers an 
opportunity for all pregnant women to be screened for symptoms of TB as per 
National Department of Health guideline and as recommended by WHO [22, 26, 
30]. Therefore, the research question underpinning this study was: “What are 
TB screening practices during BANC in health facilities in uThungulu Health 
District for pregnant women living with HIV?” 
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1.3 Aim  
The aim of the study was to describe, and analyze factors associated with, TB 
screening for pregnant women living with HIV in BANC services in uThungulu 
District, in the KwaZulu-Natal Province of South Africa.  
1.4 Objectives  
The objectives of this study were to: 
 Determine the proportion of pregnant women living with HIV screened for TB 
at initiation of BANC in 2011/12, in health facilities in uThungulu District. 
 Analyze health system factors associated with TB screening of pregnant 
women living with HIV at initiation of BANC in 2011/2012, in health facilities 
in the UThungulu District.   
1.5 Significance of the study  
The study explored the health system factors associated with screening for TB 
in pregnant women living with HIV at initiation of BANC. The study was 
undertaken to identify possible areas of health system intervention to improve 
adherence to the National Guideline for the management of pregnant women 
living with HIV, at primary level health care facilities, thus improving the quality 
of care. TB screening implemented at initiation of BANC should contribute to 
early TB detection and management, which in turn should contribute to better 
maternal outcomes and a reduction in TB-related maternal mortality.  
1.6 Overview of the dissertation  
Chapter 1 highlighted the study background, the problem statement, and the 
aim and objectives, and the significance of the study. 
Chapter 2 shall present the literature reviewed and the conceptual framework 
that guided data collection. 
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Chapter 3 shall present an article manuscript, inclusive of the study results, that 
will be submitted to the BioMedical Central (BMC) Pregnancy and Childbirth 
journal.  
Chapter 4 shall present an integrative discussion, inclusive of the study 
limitations, and recommendations that arise from the study. 
Finally the annexures will be presented, which include: the study protocol 
(inclusive of the data extraction tool, information sheet and informed consent); 
the acknowledgment of registration of the study for degree purposes; the 
research ethics approval; the letter from the UThungulu Health District granting 




CHAPTER 2: LITERATURE REVIEW  
2.1. Introduction  
This chapter presents a literature review on TB screening in pregnant women 
living with HIV. The first section of this chapter describes the literature search 
strategy. The body of the chapter will discuss the status of the TB epidemic, the 
epidemiology of TB, the signs and symptoms of TB, TB in pregnancy, Isoniazid 
Preventative Therapy (IPT), TB treatment, health system aspects in the delivery 
of quality TB care, and the conceptual framework guiding the data collection for 
study. 
2.2. Literature search strategy 
A traditional narrative literature review was implemented to provide a summary 
of current literature relevant to the research question. The search terms used 
were: “tuberculosis”, “screening” and “HIV in pregnancy”.  The electronic data 
bases searched were Google Scholar, PubMed, Science Direct, and BioMedical 
Central. Electronic journals searched were the Lancet, AIDS, Clinical Infectious 
Diseases, Reproductive Health Matters, International Journal of Gynecology & 
Obstetrics (IJGO) and Tuberculosis and Lung Disease. Limiters applied 
included the language of publication, which was English, and the year of 
publication, which was from 2000 to 2015. The period of publication was 
backdated to the year 2000 because of the limited number of published articles 
retrieved from 2010 onwards.  
2.3. Status of the TB epidemic 
2.3.1 Global status 
TB is a burden worldwide, second to HIV, with high mortality due to a single 
infectious agent [1-3, 5, 6, 39, 40]. TB was declared  a global public health 
emergency in 1993 by the World Health Organization (WHO) [39, 41]. Through 
concerted public health efforts, the global incidence of TB decreased by about 
1.5% each year from 2000 to 2013 [7]. Still in 2013, 9 million people developed 
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TB [7]. Of these, an estimated 3.3 million were women and 550 000 children [6, 
10].  The GLOBAL TUBERCULOSIS REPORT 2014 showed a substantial 
burden of TB in terms of morbidity and mortality among adult women [10]. In 
resource-limited settings, women of child-bearing age (especially between 15 
and 24 years) are disproportionately affected by TB because of the high HIV 
prevalence rates in this age group [1, 3, 7, 11, 39, 42].  
A drop of 45% in overall TB mortality was observed between 1990 and 2013, [9, 
10, 39], and by 22% between 2000 and 2015 [8]. The greatest burden of TB 
mortality is in the African and the South Asian regions, where three quarters of 
deaths happened [6, 7]. The countries with the greatest burden were South 
Africa and India, contributing a third of global deaths [6-8]. A large TB mortality 
burden was among women and children [6, 7, 10, 39]. Among women, those 
who are HIV infected have the greatest TB mortality compared to those who are 
uninfected [6, 8].  
2.3.2 South African TB status  
With regards to TB incidence, South Africa ranks the highest, both globally and 
in sub-Saharan Africa, with a TB incidence of 593/100 000 in 2013 [38, 43]. 
However, there has been a gradual decline in the TB incidence in South Africa 
from 832/100 000 in 2009 to 593/100 000 in 2013 [43]. In 2013, ten of the 33 
districts reporting a TB incidence higher than the national incidence were in the 
Province of KwaZulu-Natal (KZN) [38, 43]. Among the ten districts was the 
uThungulu District, which reported a TB incidence of 888/100 000 in 2013 [38, 
43].  
The TB case finding index in South Africa is 2.4% and in KZN it is 2.7% [38], 
with uThungulu District having the lowest case finding index in KZN at 2.6% 
[38].  The TB treatment success rate in South Africa increased from 76.1% in 
2012 to 77.9% in 2013, slowly approaching the national target of 82% [43]. KZN 
was almost on target in 2013, with a TB success rate of 81.8%, which was also 
above the national average [43]. Albeit a high burden of TB in uThungulu 
district, the TB treatment success rate in 2013 was the highest in South Africa 
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at 90.1% [38, 43]. The more effective TB management in uThungulu District 
offers hope to the management of TB in pregnant women living with HIV [38].   
2.4. Epidemiology of TB  
TB is a treatable airborne disease caused by Mycobacterium tuberculosis [3, 
44, 45]. The tubercle bacillus, which is the causative organism of tuberculosis, 
was demonstrated by Robert Koch in 1882, who was awarded the Nobel Prize 
in 1905 for his discovery [44-46]. In 1895 Wilhelm Roentgen developed X-rays 
which advanced diagnostics for TB [44]. In 1908, the French scientists Albert 
Calmette and Camille Guerin grew Koch’s bacillus in several mediums to 
decrease virulence and increase the capacity to produce immunity [44]. This led 
to the vaccine called Bacillus Calmette–Guérin (BCG) named after the two 
founders [45, 46]. The BCG vaccine was introduced in France in 1921 [44-47]. 
In 1948, India and Pakistan became the first countries other than Europe to 
introduce trial BCG vaccinations [46]. The BCG campaign was extended to 
developing countries in the 1950s and first used by Greenland in 1955 [44, 45, 
47]. 
Active tuberculosis can be contagious, while latent tuberculosis is not [3, 42, 
47]. The TB incidence has risen with the rising burden of human 
immunodeficiency virus (HIV) [3, 11, 12, 22, 42], because people living with 
HIV, whose immune system is weakened, have  20–37 times the risk of 
developing  opportunistic TB progressive disease compared with HIV negative 
individuals [3, 11]. 
TB is more common among men than women, affecting mostly adults in the 
economically productive age groups [8, 39]. In resource-limited settings, 
including in South Africa, women of child-bearing age (especially between 15 
and 24 years) are disproportionately affected by TB because of the high HIV 
prevalence in this age group [3, 11]. An estimated one-third of deaths due to 
tuberculosis occur among women of childbearing age [12, 22].  TB infection in 
people living with HIV further increases the spread of extra-pulmonary TB [3].  
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2.5. Signs, symptoms and diagnosis of TB 
The general symptoms of TB disease include unexplained weight loss, loss of 
appetite, night sweats, fever, fatigue, and chills, and the symptoms of 
pulmonary TB include coughing for 3 weeks or longer, hemoptysis and chest 
pain [12, 22, 30, 48]. The clinical features of TB in pregnant women are the 
same as in non-pregnant women [3, 7, 12]. 
Several tests are used to diagnose TB, depending on the type of TB suspected. 
Medical history, physical examination, TB skin test or TB blood test, chest 
radiograph (X-ray), and appropriate laboratory tests may be used to exclude TB 
infection [42]. The diagnosis of TB in pregnancy is the same as in the general 
population: by taking a history to identify the risk factors for TB infection and 
using the specific symptomatology screening tool to identify the presence of 
symptoms which may be suggestive of TB [3, 7, 10, 28]. Screening for TB 
during pregnancy, while recommended, does not seem to be undertaken 
routinely, which contributes to a delay in diagnosis and increased mortality [22, 
42]. 
Signs of maternal TB may vary from mild cough, fever and fatigue to weight 
loss and hemoptysis [3, 11, 28, 49, 50]. In South Africa, routine screening for 
TB in pregnancy is standard protocol at each antenatal care visit [26]. Pregnant 
women living with HIV and co-infected with TB are most likely to be identified 
through routine screening and to be asymptomatic [3, 32]. In South Africa, of 
the pregnant women reporting cough of two weeks or more, 60% were 
diagnosed with TB. Of these pregnant women, less than 30% had fever or night 
sweats [2, 49]. The absence of TB symptoms makes it difficult to suspect TB 
and has a negative predictive value of 90.0-97.7% [2, 49].  
TB may affect any tissue of the body.  However pulmonary TB is the most 
common form of the maternal disease with bronchopneumonia, cavitation, 
bronchiectasis, interstitial pneumonitis and/or pleural effusion [11, 12]. TB 
infection in pregnancy may be a challenge to diagnose as the early symptoms 
often are non-specific, such as malaise and fatigue, which may be attributed to 
pregnancy and not raise the suspicion of TB infection [11, 12, 40]. 
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HIV/TB co-infection, multi/extensive drug resistant (MDR/XDR) TB, the 
complexity of TB/HIV co-infection and immune responses to TB contribute to 
the challenges of TB screening in pregnancy [51, 52].  
2.6. TB in pregnant women 
Pregnant women are more susceptible to develop active TB than other 
population groups [1, 3, 53]. However, at all levels of health care in sub-
Saharan Africa, diagnosis of TB in pregnant women is overlooked [53], even 
though TB is one of the leading non-obstetric causes of maternal mortality [3, 
11, 19, 42, 49, 53]. TB incidence in pregnant women is expected to be the 
same as in the general population [1, 3]. TB is often not detected in pregnancy 
due to lack of symptoms [3, 32].  
TB infection may be worse during pregnancy due to factors associated with 
poor nutrition, immunodeficiency and/or other coexisting disease [11, 12]. 
Pregnancy was previously thought to aggravate or slow down the course of TB 
but evidence has since shown that it is not the case [49]. However, in an era of 
HIV with its profound effects on the immune system, TB seems to be 
aggravated in pregnancy as a result of HIV [11, 49]. It is argued that the TB 
presentation in pregnant women is similar to non-pregnant individuals with 
pulmonary TB [11].  
The critical step in making the diagnosis even in pregnancy is based on 
identification of risk factors for TB infection and on specific enquiry about 
symptoms suggestive of TB [11, 12, 22]. Active TB during pregnancy is 
associated with spontaneous abortion, a smaller uterine symphysis to fundal 
height for the expected gestational age, preterm labor and adverse perinatal 
outcomes [3, 22]. 
Few national programs collect or report pregnancy-specific tuberculosis data to 
the WHO [49]. 
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2.7. TB/HIV co-infection in pregnancy  
TB/HIV co-infection leads to difficulties in the diagnosis and treatment of TB [54, 
55]. HIV/TB co-infection is common in areas with high prevalence of TB 
especially in South Africa [22, 40]. TB is the most frequent fatal opportunistic 
disease affecting people living with HIV especially in the first three months of 
starting antiretroviral therapy (ART) [41]. Although ART reduces the likelihood 
of developing TB disease, studies have shown that TB incidence among people 
living with HIV receiving ART is still greater than in the general South African 
population [56]. The development of TB disease has been associated with 
increased HIV replication and reduced CD4 cell counts, possibly contributing to 
the advancement of HIV infection [57]. 
TB/HIV co-infection has emerged as a major non-obstetric cause of maternal 
morbidity and mortality [12, 18, 58]. Increases in TB-associated maternal 
deaths have been reported from South Africa and Lusaka in Zambia [3, 11, 22]. 
Both TB and HIV infection have been identified as contributing independently 
towards maternal mortality and poor perinatal outcomes [49, 57]. However in 
combination, TB and HIV infection have a greater harmful impact than their 
individual effects [49, 57]. The relative risk of death in mothers with TB and HIV 
co-infection compared to those with TB without HIV co-infection was 3.2 [19, 
22, 59]. HIV-infected TB cases cause 10% of maternal deaths in Africa [12]. 
HIV and TB effects are more deadly in pregnancy, and may contribute 
significantly to maternal morbidity and mortality. Over 50% of the maternal 
mortality occurring in mothers with TB in pregnancy is due to TB/HIV co-
infection [13, 22, 58]. Pregnant women living with HIV had 3.8 times increased 
risk of severe elevated Liver Function Tests (LFTs) compared to non-pregnant 
women, and hepatotoxicity from ART during pregnancy ranged from 0.5% to 
25.9% [11].  
2.7.1 Vertical transmission of HIV and TB 
TB/HIV co-infection in pregnancy is associated with higher vertical transmission 
of HIV compared to women with HIV alone [1, 21, 34, 51, 53, 60, 61]. In 
pregnant women who have TB, the fetus is exposed to the infection [12, 25]. 
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The exact risk of transmission to the fetus/newborn is unknown, but progression 
from infection to disease is highest during the first year of life [12]. The extra 
pulmonary forms of TB disease, e.g. peritoneal, renal, lymph node and 
meningeal TB, constitute greater risk factors for congenital TB [5, 11, 40].   
Extra pulmonary TB has also been shown to increase all-cause neonatal 
mortality [5, 40]. Congenital TB, though rare, is associated with high perinatal 
mortality [12]. 
TB-infected mothers had a 6.4 times higher perinatal mortality than those TB-
uninfected [3, 11, 40].   Adverse outcomes were higher where the maternal TB 
was diagnosed in the third trimester, TB disease was in an advanced stage, or 
where the mother had been non-compliant with treatment intervention [3, 5, 40]. 
2.8. TB treatment 
Lessons learned from the HIV programme have shown that, since TB is 
curable, if the gap between those diagnosed with TB and those who are ill can 
be closed, reduction of TB can be accelerated towards global elimination [7]. 
The effectiveness of care is known only in about two-thirds of the estimated 8.6 
million incident cases of TB [7, 10]. THE GLOBAL TUBERCULOSIS REPORT 
2014 estimates that in 2013 there were 3 million people with active TB, either 
not diagnosed or not reported [6, 10].The WHO recommends that the treatment 
of TB in pregnancy should be the same as that in non-pregnant women; the 
only exception being that streptomycin should be avoided in pregnancy as it is 
ototoxic to the fetus [11, 30]. Starting TB treatment late in pregnancy has been 
associated with neonatal mortality and extreme prematurity [11]. 
Early initiation of antenatal care and availability of diagnostic facilities for TB 
enhance TB screening, early diagnosis, and treatment for pregnant women 
living with HIV [52]. Provision of proper resources for integration of TB and HIV 
programmes contributes to improved screening and diagnosis of TB in pregnant 
women living with HIV [32, 59]. TB screening should be integrated into maternal 
care so that pregnant women living with HIV can receive preventative therapy 
[49, 59]. Even in settings where infrastructure and human resource capacity 
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were limited, there was compelling evidence for the utilization of the TB 
symptomatology screening tool [59].  
It is argued that although the Communicable Disease Centre (CDC) and WHO 
recommend early treatment of latent tuberculosis in pregnant women living with 
HIV, on treatment pregnant women may be at particular risk for drug-induced 
liver injury [49]. 
2.9. Preventative therapy 
TB control is failing in South Africa due to the failure to treat latent TB infection, 
using INH prophylaxis in the general population, including in people living with 
HIV [62]. INH is administered to individuals with latent infection with TB in order 
to prevent progression to active TB disease. The eligibility criteria for isoniazid 
preventive therapy (IPT) is pregnant and breastfeeding women living with HIV 
and the duration depends on the Tuberculin Sensitivity Test (TST) [63]. If TST 
positive the duration is 36 months, negative and not done the duration is 12 
months [63]. The INH dosage should be 5mg/kg/day and maximum of 300mg 
with Vitamin B6 25mg/day [63]. 
The benefits of IPT in preventing TB outweigh the risks [3, 12]. After excluding 
active TB disease, IPT can be started at any time during pregnancy and should 
be completed if a woman falls pregnant while taking IPT [3, 12]. IPT was 
incorporated by WHO in 2004 as one of the twelve collaborative TB/HIV 
activities and included in 2008 as part of the three “I’s” for TB/HIV which are 
IPT, infection control for TB, and intensified case finding [41, 50].  
Detection of TB can be beneficial to pregnant women living with HIV and their 
unborn babies [1]. Antenatal care provides an important contact between 
pregnant women, regardless of HIV status, and the health system [1]. In India, 
active TB screening and targeted use of IPT among women living with HIV was 
recommended to prevent postpartum TB and mother to child transmission of TB 
[3, 25, 49]. Babies born to mothers with TB should be commenced on INH 




In most countries, even with a supportive national policy for IPT, there is a gap 
between policy and implementation. Concerns exist by programme managers 
and health providers that INH monotherapy for undetected TB may cause 
development of INH resistance [41]. Yet studies have shown no significant 
increased risk of INH mono-resistance following IPT [41].  Concurrent 
administration of ART and IPT has demonstrated a TB risk reduction of 76–89% 
in observational studies from both South Africa and Brazil [59].  
2.10. The health system aspects of the quality of TB care 
The high burden of maternal HIV/TB co-infection over burdens the health care 
system [20, 53, 64]. In some HIV endemic countries, gains in maternal mortality 
were reversed [64]. Pregnant women living with HIV, and who have comorbidity 
with active or subclinical TB are often overlooked [53]. Services for pregnant 
women living with HIV should incorporate routine TB screening and provision of 
IPT. IPT should not be viewed by the community as a stand-alone TB 
prevention intervention [41, 53]. TB screening and IPT indicators should be 
monitored with TB/HIV integration [41].  
Effective integration of TB service provision should be advocated, while 
maintaining some vertical elements for essential functions, such as drug supply, 
monitoring, and surveillance.  The vertical TB programme components may be 
restricted to a small central team providing general oversight [53]. Poorly 
functioning management systems in each health service should be addressed, 
including ensuring adequate human resources [50]. 
2.11. Conceptual Framework  
Maternal health care outcomes are dependent on health system functioning 
[65]. The WHO defines the health system as a system whose primary purpose 
is to promote, restore and maintain health [66]. In 2007 the WHO developed a 
framework for health systems, composed of six building blocks: leadership and 
governance;  health care financing; human resources for health; medical 
products, vaccines and technology; health information systems; and health 
service coverage [65, 66]. Blaauw and Kekana have elaborated the WHO 
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conceptual framework, showing the relationship between the health system 
building blocks, essential packages of care and maternal outcomes [65, 67] 





Figure 1: Map of key components of maternal and newborn health [65, 67] 
 
The key health components contributing to maternal health, as depicted in the 
conceptual framework developed by Blaauw and Kekana [65]  are explained as 
follows: 
2.11.1 Leadership and governance  
Leadership is a process of social influence, which maximizes the efforts of 
others, towards the achievement of a goal.  Governance is the way to hold 
organizations accountable [68], with governance structures liaising with various 
stakeholders at different levels of the health system for the development of 
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conducive policies and environments of care, towards the promotion and 
protection of the health of communities [69].  
Leadership and governance are viewed as  key drivers in the provision of 
quality care for optimal maternal and newborn outcomes, as well as client and 
health worker satisfaction [65].   However should involve managers in positions 
of responsibility to effect  change within organizations [70].  
 Effective leadership and governance contribute to health systems 
strengthening and include PHC supervision, PMTCT mentorship, clinical audit 
and the availability of an active clinic committee for ensuring accountability to 
community. Adequate financing is ensured by allocating a budget which is 
known by the clinic manager and staff for BANC services. 
Supervision is an intervention provided by a senior member of a profession to a 
junior of same profession [68]. The relationship includes assessment of 
performance over time and has the concurrent purposes of monitoring the 
quality of professional services offered to the clients served and further 
improving professional functioning of lower ranking members [43] [38]. Primary 
Health Care (PHC) supervisory visits are intended to assist in identifying and 
addressing gaps in the provision of priority programs at clinics, Community 
Health Centers (CHC) and community day centers [38]. The South African 
target of at least one supervisory visit per month per facility was achieved in 
80% of facilities nationally. In KZN it was met in 60% of facilities from 2011 to 
2013, while in uThungulu at was met in 70% of facilities [38].  
Clinical audit is a quality improvement process with the purpose of improving 
patient care and outcomes through a systematic review of care against explicit 
criteria, and through the implementation of corrective actions [71].  As IPT 
initiation has been shown to be beneficial to people living with HIV, supervisors 
should facilitate clinical audits to ensure that TB screening using the simple 
symptom-based clinical questionnaire is implemented for pregnant women 




2.11.2 Policy and legislation 
 
Public policy development is a process that guided actions at different levels 
involving contests of interests within and outside government [69]. Legislation 
refers to laws which serve to legally guide certain actions and ensure others are 
carried out [69].   Policies provide a plan of action which act as a guide towards 
making sure legislation is complied with [69].  
 
The number of countries that issued policies for IPT implementation increased 
from 8 to 102 between 2002 and 2009 [41]. However, a gap has been observed 
between policy formulation and its implementation, as only 50% of the countries 
with supportive IPT policies were reporting on IPT implementation to WHO [41].    
In South Africa, TB screening for pregnant women living with HIV, with IPT 
initiation, was included in the national consolidated guideline for the prevention 
of Mother-To-Child Transmission of HIV (PMTCT) and the management of HIV 
in children, adolescents and adults, as a basic package of care, which is an 
example of how policy and legislation, and the implementation of the guideline 
has a potential to contribute towards good maternal and newborn outcomes.  
 
 
2.11.3 Financing  
 
Health care financing has the potential to have a positive or negative impact on 
maternal health provision [72]. South Africa’s district health service expenditure 
per capita increased from R659 in 2004/05 to R1 327 in 2012/13, with KZN 
below the national average at R1 301, while UThungulu District’s per capita 
expenditure was R1 352 [38]. Competition for funds among programmes is 
fierce [73].  
 
Global financial assistance to maternal and neonatal health was estimated at 
more than US$663 million in 2003 [73]. An estimated extra US$1 billion in 2006, 
increasing to US$6 1 billion in 2015, was needed to increase financial coverage  
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to desired levels [73].  The estimates exclude the cost of incentives to improve 
quality of care, promoting staff retention in rural areas, and prevention of the 
imposed informal charges [69, 72-74]. 
 
The extent to which  health system investment will affect maternal health is hard  
to quantify and is a challenge to cost-calculating exercises [73]. 
 
Studies have shown that there has been an increase in the availability of funds 
to support collaborative TB/HIV activities through the President’s Emergency 
Plan for AIDS Relief (PEPFAR) and the Global Fund to AIDS, TB and Malaria 
(GFATM) [41]. Provision of IPT to people living with HIV has been found to the 
more cost effective than the cost of medical care and social costs. However the 
study, conducted in South Africa, excluded those who were also on ART [41]. It 
was therefore recommended by the Global TB Drug Facility that INH should be 
available as a TB prevention commodity for people living with HIV as part of 
core services [41]. 
2.11.4 Human resources  
Understaffing, particularly in rural, poor areas impacts negatively on maternal 
and newborn outcomes [75]. Furthermore, the quality of care provided to 
pregnant women, and whether standard protocol of management are followed, 
determine maternal and newborn outcomes [72]. The existing personnel may 
experience increased workloads and job dissatisfaction, and may have to 
assume tasks for which they are not trained. Therefore shortages of maternal 
health professionals should be addressed within an overall human resources 
policy [75]. 
Human resource capacity can be increased through in-service training, 
increased output from training institutions of health care workers competent to 
work at primary level, task shifting, increased flexibility in health service roles, 




In a cross sectional operational study conducted in Soweto (South Africa), the 
obstacles to integrating TB screening with PMTCT services included poor 
morale of clinical staff and low motivation in staff to take on new responsibilities 
without additional remuneration [1]. Additional training and supportive 
supervision could potentially improve identification and investigation of TB 
suspects [1]. 
 
2.11.5 Information  
Information management is central to health care delivery [76, 77]. The success 
of health care depends on the collection, verification, analysis, exchange and 
utilization of information, within and beyond the organization [74, 77, 78]. 
However the electronic TB register does not have segregated data for pregnant 
women.  
 
A TB Suspect Register is used in some countries and in Malawi it is called the 
Chronic Cough Register [79]. The Register, under the control of the district or 
health facility TB officer became very helpful in tracking patients that presented 
for investigation of chronic cough [79]. A pregnant woman living with HIV who 
has any one of the Pulmonary TB symptoms of cough, fever or weight loss 
should be clinically assessed and initiated on cotrimoxazole preventive therapy 
[79].  
 
Many resource-restricted countries have not established a system to monitor 
and evaluate the implementation of IPT [41]. TB screening and IPT provision 
indicators should be adopted by all HIV implementers [41]. The strength of a 
health system offers a key and sustainable mechanism to influence priority 
population level indicators of health [66].  
 
2.11.6 Support services   
A referral system is defined by WHO as “a process in which a health worker at 
any one level of the health system, having insufficient resources (drugs, 
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equipment, skills) to manage a clinical condition, seeks the assistance of a 
better or differently resourced facility at the same or higher level to assist in, or 
take over the management of, the client’s case” [80]. Components of a referral 
system include, among others, clarity of level and role of each facility, 
availability of communication and transport, referral register to monitor follow-up 
and gather statistics, back referral and consistency of follow-up [80].  
 
A functional referral continuum can increase client and provider satisfaction 
[81]. At the public health level, linkages between integrated packages can 
maximise the efficiency with which the scarce human and financial resources 
available for health care are used [81]. The continuum of care is the basis of 
health care in many countries, especially those with government-funded health-
care systems [81]. 
 
2.11.7 Package for indirect obstetric care  
A health package can refer to an entire national health package or to specific 
interventions designed to address a particular outcome [81]. For antenatal care 
to be effective, all pregnant women need a minimum of four focused visits, at 
specific times during the pregnancy, and with evidence-based content [81]. 
Care for women during pregnancy improves health through preventive 
measures, and by prompt detection and management of complications [81]. 
Essential components of a focused antenatal-care package include screening 
for and treatment of disorders including screening and management of HIV and 
TB in pregnancy [81]. 
 
TB screening for pregnant women living with HIV and provision of IPT should 
be part of core services [41].  
2.11.8 Community package  
A family and community care package aims to improve healthy home 
behaviours and to increase demand for outreach and clinical services. Effective 
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behavioural and preventive interventions that can be delivered through this 
package which includes prevention and promotion of health [66, 81]. 
 
Meaningful engagements of pregnant women living with HIV and their 
communities should be conducted in planning and implementation of TB 
screening and IPT [41]. IPT should be advocated in communities as an 
evidence based effective intervention to prevent TB in women living with HIV 
and communities should be empowered to demand IPT when they are in 
contact with PMTCT providers [41].   
 
There is little country specific research that has been done to explore ways in 
which health system elements do impact on maternal health outcomes [66, 72].  
The health system building blocks aim to support a health system to ensure 
coverage in the prevention and management of illness and to preserve mental 
and physical well-being for all individuals, equitably and efficiently, within a 
specified geographic area [66]. The health system activities range from direct 
quality service provision through accessible clinics and hospitals to 
communities that will respond to prevention strategies and health education. 
[65]. The expected outcomes are maternal and newborn health, and patient and 
health worker satisfaction [65].  
TB management is one of the required services in the essential package of care 
for pregnant women attending BANC at any level of the health system [26]. 
According to the national HIV, TB and PMTCT guidelines, pregnant women 
living with HIV should be screened of TB at every visit and provided with IPT or 
TB treatment whichever is appropriate [26] 
 
 
2.12.  Summary of the literature review section 
Through the review of the literature it has been shown that TB is a burden 
globally and in South Africa. It has also been shown that there are concerns 
about maternal and neonatal complications associated with TB, especially if 
there is co-infection with HIV. There was no specific literature available to 
determine TB incidence during pregnancy, and so it was assumed to be as 
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prevalent as in the general population. TB symptomatic screening has been 
shown to be effective in identifying pregnant women living with HIV without TB, 
for whom IPT is indicated, and for those with symptoms, for further investigation 
and initiation of TB treatment. The components of the conceptual framework 
underpinning the study have shown the relationship between health system 
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Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) co-infection 
in pregnancy are risk factors for both maternal and perinatal outcomes. TB 
is preventable in pregnancy in women living with HIV by initiating Isoniazid 
(INH) prophylactic therapy (IPT) after TB has been excluded upon 
screening. This study explored health system factors associated with TB 
screening of pregnant women living with HIV in the basic antenatal care 
(BANC) services in a health district in the Province of KwaZulu-Natal, 
South Africa.  
Methods 
An observational cross-sectional design, with descriptive and analytic 
components, was carried out. Multi-stage sampling was used, firstly to 
select health facilities and then to select pregnant women living with HIV 
initiating BANC. A structured interviewer-administered questionnaire and 
data extraction tools were used to collect data. Data was analysed using 
descriptive and analytic statistics, using mixed effects logistic regression 
with cluster effect, and doer and non-doer analysis and Fischer’s exact 
analysis.  The level of statistical significance was set at p=0.05. 
Results 
The results of the study showed that pregnant women living with HIV were 
three (3) times more likely to be screened for TB in clinics where 
personnel had been trained on TB management, on Antiretroviral Therapy 
(ART) for pregnant women, and on the Prevention of Mother to Child 
Transmission (PMTCT) of HIV; and in clinics with a full-time enrolled 
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nurse.  Furthermore, clinics where ALL pregnant women living with HIV 
were screened for TB (doers) were more likely to have: a full-time midwife; 
personnel at all levels trained on TB management, on ART for pregnant 
women, and on PMTCT; and a policy to trace pregnant women who do not 
adhere to their scheduled subsequent visit.   
Conclusions 
Health system factors associated with the implementation of the National 
Department of Health Guideline and World Health Organisation 
recommendation for the screening of TB in pregnancy for women living 
with HIV include appropriate, and trained, personnel, with a policy to 
follow-up pregnant women who do not adhere to scheduled appointments. 
Key words: HIV, isoniazid preventative therapy, pregnant women, 





Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) co-infection 
in pregnancy are risk factors for both maternal and perinatal outcomes [1, 
12, 13, 64, 82, 83]. TB is preventable in pregnancy by initiating Isoniazid 
(INH) prophylactic therapy (IPT) after TB has been excluded [3, 17, 49, 
79]. In South Africa, TB is the third highest non-pregnancy related 
avoidable cause of maternal death, while in KwaZulu-Natal (KZN) TB is 
the second highest, accounting for 14% of maternal deaths [11, 15, 16]. 
Delayed diagnosis of TB, and delayed or lack of treatment in pregnancy 
contributes to neonatal TB [34, 35]. Studies have shown that TB in 
pregnant women living with HIV increases maternal and perinatal 
morbidity and mortality, including the risk of vertical transmission of HIV [3, 
13, 20, 21]. 
To facilitate the early detection and management of TB in pregnant 
women living with HIV, the National Department of Health in South Africa 
has issued guidelines, as per the World Health Organization (WHO) 
recommendation, to screen all pregnant women living with HIV for TB [26]. 
The guidelines call attention to the fact that pregnant women living with 
HIV often have other health issues. Therefore, the necessity of integrating 
HIV services with Primary Health Care (PHC), and with maternal, newborn 
and child health (MNCH) and TB services, in order to provide more client-
centred care [26]. Pregnant women living with HIV should be screened for 
TB and if there is any symptom suggestive of TB, appropriate investigation 
using sputum/Gene-Xpert and TB culture should be used [26]. However, 
inadequate screening for TB during antenatal care in pregnant women 
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living with HIV has been identified as one of the contributory factors to 
adverse maternal and perinatal outcomes [32-35]. TB screening is part of 
the essential package of care to be provided during antenatal care to 
pregnant women living with HIV [13, 15, 41, 64, 65]. Health system 
performance influences the provision of care [22, 31, 83]. The conceptual 
framework proposed by Blaauw and Kekana [65] (see Figure 1) formed 
the basis for attaining the purpose of this study, which was to evaluate 
health system components associated with TB screening for pregnant 
women living with HIV initiating basic antenatal care (BANC), in 2011/12, 
in a District in the Province of KwaZulu-Natal.  The health system 
components comprised: policy and legislation; leadership and governance; 
health financing; human resources for health; information system; and 
support services [65]. 
 
Methods  
An observational cross-sectional study design, with descriptive and 
analytic components, was conducted in primary level clinics that provide 
BANC services, in a Health District in the Province of KwaZulu-Natal, 
South Africa. 
The study population comprised pregnant women living with HIV initiating 
BANC in health facilities in the District. Pregnant women aged 18 years 
and older who were confirmed to be living with HIV at initiation of BANC 
were included in the study.  Pregnant women testing negative for HIV at 
initiation of BANC were excluded from the study.  
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Multi-stage cluster sampling was implemented. Firstly, all six Level One 
public sector hospitals in the Health District were selected. Secondly, a 
simple random sample was drawn of fixed clinics providing antenatal care 
services within the catchment area of each Level One hospital.  Fifteen 
(15) of a total of 46 fixed clinics were selected using probability 
proportionate to size. The number of 15 fixed clinics was based on sample 
of 30%, which is the required sample size in a descriptive study not testing 
a hypothesis [84, 85].  Thirdly, within the randomly sampled clinics, 
systematic sampling was implemented to select every third pregnant 
woman living with HIV, recorded in the BANC register as having initiated 
BANC between April 2011 and March 2012, and as being counselled, 
tested and positive for HIV. A total of 845 records of pregnant women 
living with HIV were sampled.  
To assess the proportion of pregnant women living with HIV who were 
screened for TB, a data extraction tool was used to retrieve data from the 
BANC register held in the clinic.  To assess health system factors 
associated with TB screening, data collection comprised: structured 
interviews, utilising an interviewer-administered questionnaire, with 
antenatal care clinic managers on duty on the day of data collection; and a 
data extraction tool for extracting data from clinic administrative records. 
Data was collected from September 2013 to March 2014.  
Outcome and exposure variables were collected simultaneously, reducing 
the expense of the study [86]. All data was cleaned, coded, and entered 
on a Microsoft excel spreadsheet. The data was double entered, and the 
two files compared for any discrepancies. Discrepancies were corrected 
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against the original paper records. Data was exported to the IBM SPSS™ 
21 software for analysis.  At the individual level, mixed effects logistic 
regression with cluster effect was used to measure the strength of 
association between outcome (pregnant women living with HIV screened 
for TB) and exposure variables (health system factors) [87].  At the clinic 
level,  doer and non-doer analysis was implemented  to determine the 
relationship between outcome (ALL pregnant women living with HIV 
screened for TB) and exposure variables (health system factors) [87]. A 
clinic where ALL pregnant women living with HIV were screened for TB 
was classified as a ‘doer’ and one where not all were screened for TB was 
classified as a ‘non-doer’. Fischer’s exact analysis was used to measure 
the probability of a clinic being classified as a doer or a non-doer in 
relation to the exposure variables.   
The basic principles of research ethics, that is: beneficence, which is 
ensuring protection for participants; autonomy, which respects a person’s 
decision to participate or not to participate in the study; non-maleficence, 
that is doing no harm; and justice, which is random selection of 
participants, were applied in this study. Ethical clearance was obtained 
from the UKZN Biomedical Research Ethics Committee (Reference 
number BE142/11).  Permission to conduct the study in the clinics was 
obtained from the District Health Manager. Participants were provided with 
full information on the study and were asked to sign an informed consent 
form when they agreed to participate in the study. They were assured of 
confidentiality and also were assured of no negative consequences should 





Demographic characteristics and obstetric history of pregnant 
women living with HIV 
The mean age for the pregnant women living with HIV was 26 years. The 
mean gravidity was 2 and mean parity was one. Gestational age (GA) at 
initiation of BANC ranged from 4 to 39 weeks, with a mean GA of 19 
weeks. The proportion of women who initiated BANC before 20 weeks GA 
was 47% (See Table 1). 
 
TB screening of pregnant women living with HIV 
Of the 845 pregnant women living with HIV, 76% (n=645) were screened 
for TB. However, only 19% (n=124) of those who had no TB symptoms 
were initiated on IPT.  Only 9% (n=11) pregnant women living with HIV 
who had symptoms of TB had sputum collected for TB diagnosis.  
Of the fifteen clinics sampled, one third (n=5) implemented TB screening 
for ALL the sampled pregnant women living with HIV and were classified 
as ‘doers’.  
 
Health system factors associated with TB screening of pregnant 
women living with HIV 
Leadership and governance, financing and information  
Descriptive analysis revealed that 60% (n=9) of clinics reported being 
visited by the PHC supervisor in the previous month, and 13% (n=2) by 
the PMTCT mentor. Pregnant women living with HIV were more likely to 
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be screened if attending a clinic that had been visited by: a PHC 
supervisor (OR 4.1; p=0.50; 95%CI 0.65-265.46) and a PMTCT mentor 
(OR 2.1; p=0.81; 95%CI 0.004-1217.6) although neither association was 
found to be statistically significant.  Among the clinics, 80% of doers 
compared to 50% of non-doers reported being visited by the PHC 
supervisor in the previous month, although the probability of being 
classified as a doer was not statistically significant (p=0.58).  
The proportion of clinics reporting to have conducted a BANC record audit 
in the previous month was 13% (n=2).  Only 20% of clinic managers knew 
the budget allocation for the clinic.  All the required registers and data 
collection tools were generally available.  A majority of clinics, 88% (n=13), 
had clinic committees, and of those 62% (n=10) reported the committee 
had met as scheduled. None of these health system factors were found to 
have an association with the likelihood of pregnant women living with HIV 
being screened for TB and with the probability of clinics being classified as 
doers or non-doers.  
 
Policy and legislation 
The availability of national guidelines was assessed.  In 80% (n=12) of 
clinics both the Maternity Care Guidelines 2007 and the PMTCT 
Guidelines were available, while the National TB Manual, National TB 
Control Practical Guideline and the TB Training Manual were available in 
all clinics.  There was no association between the availability of national 
guidelines and likelihood for pregnant women living with HIV being 
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A tracing policy for pregnant women who do not adhere to their scheduled 
BANC appointments was reported in 27% (n=4) of clinics. In the presence 
of a policy to trace pregnant women who do not adhere to their scheduled 
appointment, the likelihood of pregnant women living with HIV being 
screened for TB was higher, but with borderline statistical significance (OR 
13.5; p=0.06; 95%CI 0.87-207.63). Furthermore, the probability of a clinic 
being classified a doer was of borderline statistical significance (p=0.07). 
 
Human resources 
The influence of the human resource building block was assessed by 
measuring the association between the availability, mix and training of 
personnel in the BANC services, and TB screening.  With regard to 
availability, the number of midwives per clinic ranged from 2 to 15, 
representing a midwife-to-patient ratio that ranged from 1:2 to 1:7.  With 
regard to staff mix: one-third (n=5) of clinics had a sessional medical 
officer; all clinics had a full-time midwife; 87% (n=13) had a full-time 
enrolled nurse; one-third (n=5) had a full-time enrolled nursing assistant; 
all had a full-time lay counselor; and 87% (n=13) had a full-time 
community health worker or community care giver. With regard to training, 
of the 75 midwives providing BANC in the 15 clinics, 52% (n=39) were 
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trained on TB management, 75% (n=56) on ART for pregnant woman, and 
59% (n=44) on PMTCT.   
Following logistic regression (Table 3), pregnant women living with HIV 
were more likely to be screened for TB in clinics: where midwives had 
been trained on ART for pregnant women (OR 3.1; p=0.005; 95%CI 1.42-
6.67) and on PMTCT (OR 3.0; p=0.05; 95%CI 1.01-8.98); with full-time 
enrolled nurses (OR 3.1; p=0.04; 95%CI 1.06-8.77); and with enrolled 
nurses trained on TB management (OR 7.9; p=0.001; 95%CI 2.24-27.92). 
In Table 4 is shown the proportion of clinics classified as doers and non-
doers, in the presence of the availability and training of different categories 
of staff.  Clinics with midwives, registered nurses, enrolled nurses and 
community health works trained on TB management, on ART for pregnant 
women and on PMTCT had a statistically significant probability of being 
classified as doers and providing TB screening to ALL pregnant women.   
 
Health services 
The assessment of the provision and organisation of BANC services relied 
on verbal reporting by the clinic manager.  New clients, i.e. clients initiating 
BANC, were reported to be catered for on a daily basis in 53% (n=8) of 
clinics, with the remaining clinics accommodating clients initiating BANC 
only on specific days (see Table 6). Offering, and recording the results of 
HIV counseling and testing for all pregnant women initiating BANC, and 
initiating all eligible women on antiretroviral therapy, was reported in all 
clinics.  Providing TB services daily was reported in all clinics; however the 
TB services were not integrated in BANC services.  Providing TB 
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screening for ALL women living with HIV was reported in 87% (n=13) of 
clinics.  Initiating eligible women on INH, or collecting sputum for 
bacteriological test, and, for those with positive sputum, initiating TB 
treatment, was reported in all clinics.  None of these health system factors 
showed an association with the likelihood of pregnant women living with 
HIV being screened for TB and with the probability of clinics being 
classified as doers or non-doers. 
 
Discussion  
The mean age for pregnant women living with HIV in the study was 26.7 
years. The results are similar to a study conducted by Gounder and 
colleagues on active TB case finding in Soweto in 2008, which also found 
the median age of 26 years among pregnant women living with HIV [1].  
The results show that 47% women booked for antenatal care before 20 
weeks. The results differ slightly from a study by Massyn which showed 
that in South Africa ANC initiation before 20 weeks of gestation was 45% 
and has been consistently so since 2002 [38].  
The National Guideline and WHO recommendation for TB screening of 
pregnant women living with HIV are not consistently being followed.  Just 
over three quarters of pregnant women living with HIV were offered TB 
screening when initiating antenatal care, and of those who screened 
negative for TB symptoms only about one-in-five were initiated on IPT. 
Furthermore, of the women who screened positive for TB, in only one-in-
ten was sputum collected for further investigation. Studies have shown 
that the benefits of IPT are greater than the risks even during concurrent 
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administration with ART has shown a TB risk reduction of 76–89% [3, 12, 
59].   
The availability of national guidelines alone does not translate into 
implementation.  The main purpose served by guidelines is to provide 
decision making support to health care providers, and promote uniform, 
evidence based practice and standards of care [88]. It is important to 
ensure the same standard of care is delivered to all women, whatever 
clinic they attend. Not only the proportion of pregnant women living with 
HIV screened for TB must increase, but also the proportion of clinics that 
provide TB screening to ALL pregnant women living with HIV.  Training in 
guidelines of care has been shown to have a mixed effect in changing 
practice.  In this study, having nursing staff at all levels trained in TB 
management, in ART for pregnant women and in PMTCT was significantly 
associated with the greater likelihood of pregnant women living with HIV 
being screened for TB, and the greater probability of clinics being 
classified as doers, i.e. providing TB screening for ALL pregnant women 
living with HIV.  Training can only be regarded as the first step to 
implement changes towards evidence-based practice [89, 90]. One of the 
challenges with training activities is ensuring that, within a context of high 
staff turnover [89], a core group of trained staff is retained in the health 
system [75, 91].  In this district, among the midwives working in the clinics 
sampled, just half had received training in TB management, and three-
quarters in antiretroviral therapy for pregnant women.   
Even with training, adherence to guidelines for ALL women living with HIV 
does not occur.  Further health systems interventions are required such as 
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supervision, audit of BANC records and a tracing policy for women who do 
not adhere to follow up antenatal care. Audit may help to reduce the 
discrepancy between what health care managers think and say is done, 
and what is actually done. In this study 100% clinics self-reported to be 
screening ALL pregnant women living with HIV for TB, initiating IPT to 
those eligible and taking sputum specimen to those with any of the TB 
symptoms. On record review only 33% clinics implemented TB screening 
for ALL pregnant women living with HIV. The discrepancies increased with 
regard to IPT initiation and collection of sputum, where 100% of clinics 
report adherence to guidelines, while the review of records showed that in 
only10% and 20% respectively of pregnant women living with HIV were 
the guidelines actually implemented.     
Audit provides a more realistic representation of the actual practice and 
ensuring that each of the elements of TB care in pregnant women living 
with HIV is instituted, like IPT initiation, sputum collection and initiation of 
TB treatment beyond the initial screening. Audit, combined with feedback, 
training and supervisor visits has shown moderate to strong effects in 
changing health worker practice [90].  However, audit was not an 
established practice in the clinics included in the study, although a higher 
proportion of doers than non-doers reported conducting an audit. 
Furthermore, TB screening was more likely in clinics that had received 
PHC supervision and PMTCT mentorship, although this result was not 
found to be statistically significant in this study, probably due to the small 
sample of clinics.  
38 
 
Human resource mix and training showed a higher likelihood of TB 
screening among pregnant women living with HIV, and a higher probability 
of clinics providing TB screening for ALL pregnant women living with HIV.  
However, the presence of a sessional doctor had a negative association 
with TB screening, which requires more exploration. 
None of the factors in the health service component showed an 
association with the likelihood of pregnant women living with HIV being 
screened for TB and with the probability of clinics being classified as doers 
or non-doers. However the health service component should be assessed 
in conjunction with other key components of maternal and newborn health, 
as it depends on a fully functioning health system [72].  
 
This study should be regarded as a pilot study, describing current TB 
screening practices in one District in KZN, and exploring the association 
with health system factors.  A larger study, drawing on a larger sample of 
clinics, could begin to test hypotheses that arise from this study; for 
example that supervision and mentorship visits, clinical audit, and a 
tracing system, are positively associated with TB screening.  In addition, 
the association of the organisation of services and TB screening practices 
needs to be explored further.   
 
Conclusion  
Training of staff in the management of TB, ART for pregnant women living 
with HIV, and on PMTCT, is a key building block in the health system.  
Together with other building blocks, such as leadership, which includes 
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clinics receiving supervisory and mentoring support, health care workers 
are more likely to implement TB screening for ALL pregnant women living 
with HIV. There is need for the Ministry of Health to invest in strengthening 
health system activities such as ensuring availability of skill mix, training, 
supervision and mentorship so as to improve quality of care provided to 
pregnant women living with HIV and ensuring healthcare workers 
satisfaction. 
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Age  26.7 
(26.3–27.1) 































Screened for TB (N=845) 645 76.3 
Initiated on IPT (N=645) 124 19.2 
Patients whose sputum was 




Table 3: Leadership and governance factors associated with TB screening of 
pregnant women living with HIV  





Clinics visited by PHC 







Clinics visited by PMTCT 
mentor in the past month  
2.1 0.81 0.004 1217.6 
 
Table 4: Human Resource factors associated with TB screening of pregnant 
women living with HIV  





Clinics with midwives trained on: 
TB management  2.9 0.15 0.67 12.55 
ART for pregnant women 3.1 0.005* 1.42 6.67 
PMTCT 3.0 0.05* 1.005 8.98 
Clinics with full time ENs 3.1 0.04* 1.06 8.77 
Clinics with ENs trained on 
TB management  
7.9 0.001* 2.24 27.92 
Clinics with PMTCT 
guidelines available  
0.9 0.95 0.008 86.62 





Table 5:  Human resource factors associated with women living with HIV being 
screened for TB, in 2011/2012 in the District 
 TB Screening for ALL pregnant women living with HIV 
 Non-doers (No) Doers (Yes) Fischer’s 2-
sided p-value 
 n % n %  











Full time Registered Midwife 10 100 5 100 0.005* 
Registered midwife trained on:      
TB 7 70 5 100 0.114 
 ART  9 90 5 100 0.391 
PMTCT 7 70 5 100 0.165 
Full time Registered Nurse 0 0 2 40 0.095 
Registered Nurse trained on:      
TB 0 0 2 40 0.095 
ART  0 0 2 40 0.095 
PMTCT 0 0 2 40 0.095 
Full time Enrolled Nurse 8 80 5 100 0.029* 
Enrolled Nurse trained on:      
TB 4 40 5 100 0.043* 
ART  0 0 3 60 0.022* 
PMTCT 0 0 3 60 0.022* 
F/T Enrolled Nurse Assistant 4 40 1 20 0.760 
ENA trained on:      
TB 2 20 0 0 1.000 
ART  0 0 0 0  
PMTCT 0 0 0 0  
Full time Lay Counselor (LC) 10 100 5 100 1.000 
LC trained on TB 1 10 3 60 0.022* 
LC trained on ART  1 10 3 60 0.022* 
LC trained on PMTCT 1 10 3 60 0.022* 
Full time Community Health 
Worker (CHW)/ Community 
Care Giver (CCG) 
8 80 5 100 0.532 
CHW/CCG trained on TB 3 30 4 80 0.017* 
CHW/CCG trained on ART  1 10 4 80 0.017* 
CHW/CCG trained on PMTCT 1 10 3 60 0.022* 
Full time Nutrition Advisor 6 60 3 60 1.000 
Nutrition Advisor trained on TB 0 0 0 0  
Nutrition Advisor trained on 
ART  
0 0 0 0  
Nutrition Advisor trained on 
PMTCT 
0 0 0 0  
*statistically significant results  
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Table 6:  Leadership and governance, finance, information, support services and 
health services factors associated with women living with HIV being screened for 
TB, in 2011/2012 in the District 
 TB Screening for ALL pregnant women living with HIV 
 Non-doers Doers Fischer’s 2-
sided p-value 
 n % n %  
Leadership and governance 
Was the facility visited by a 
PHC supervisor in the past 
month? 
5 50 4 20 0.580 
Was the facility visited by a 
PMTCT mentor in the past 
month? 
1 10 1 100 1.000 
Were BANC records audited 
in the past month? 
1 10 1 20 1.000 
Does the facility have a clinic 
committee? 
9 90 4 80 1.000 
How often does the committee 
meet? 
8 80 4 80 1.000 
Did the committee meet as 
scheduled? 
5 50 3 60 1.000 
Policy and Legislation  
Maternity care guideline 2007 
available? 
8 80 4 80 1.000 
PMTCT guidelines available? 7 70 4 80 1.000 
SA National TB control 
Practical guideline 
10 100 5 100  
TB training manual/ module 
available? 
10 100 5 100 1.000 
National TB Programme 
manual? 
10 100 5 100 1.000 
Finance 
Is the facility budget known? 1 10 2 40 0.242 
Information  
PHC minimum data collection 
tools? 
10 100 5 100  
Support services  
Does the facility have a tracing 
policy? 




Table 6 (continuation) 
 TB Screening for ALL pregnant women living with HIV 
 Non-doers Doers Fischer’s 2-
sided p-value 
 n % n %  
Health  services 
1st ANC available daily or on 
special days 
6 60 2 40 0.608 
TB service available daily or 
special days? 
10 100 5 100  
Was TB covered in patient 
health education in the past 
month? 
5 50 4 80 0.580 
Is TB symptom screening 
done? 
8 80 5 100 0.524 
If there are signs of TB, is 
sputum collected for 
bacteriological test? 
10 100 5 100 1.000 
If there are no signs of TB, is 
IPT initiated? 
10 100 5 100 1.000 
If client has positive sputum is 
TB treatment initiated? 
10 100 5 100 1.000 
TB suspects register? 10 100 5 100 1.000 
TB symptomatology form? 9 90 5 100  
BANC register to record all 
pregnant women? 
10 100 5 100  




CHAPTER 4: INTEGRATIVE DISCUSSION 
Inadequate screening for TB during antenatal care in pregnant women living 
with HIV, a contributory factor to high maternal mortality due to NPRI, motivated 
this study.  In the presence of national, evidence-based guidelines for the 
management of TB in pregnancy, this study explored health system factors 
associated with the TB screening of pregnant women living with HIV.  The study 
was located in BANC services in a health district in the Province of KwaZulu-
Natal, South Africa.  
 
An observational cross-sectional study design was carried out. Multi-stage 
sampling was used, firstly to select health facilities and then to select pregnant 
women living with HIV initiating BANC. A structured interviewer-administered 
questionnaire and data extraction tools were used to collect data. Data was 
analysed using descriptive and analytic statistics.  Health system factors 
associated with the likelihood of TB screening among pregnant women living 
with HIV were identified using mixed effect logistic regression with cluster effect.  
Health system factors associated with the likelihood of clinics screening ALL 
pregnant women living with HIV were identified through doer and non-doer 
analysis and Fischer’s exact analysis.   
 
The study showed that pregnant women living with HIV were three (3) times 
more likely to be screened for TB in clinics where personnel had been trained 
on TB management, on ART for pregnant women, and on the PMTCT of HIV; 
and in clinics with a full-time enrolled nurse.  Furthermore, clinics where ALL 
pregnant women living with HIV were screened for TB (doers) were more likely 
to have: a full-time midwife; personnel at all levels trained on TB management, 
on ART for pregnant women, and on PMTCT; and a policy to trace pregnant 
women who do not adhere to their scheduled subsequent visit.   
 
The implementation of the guidelines for the screening of TB in pregnancy for 
women living with HIV in this study was shown to be associated with health 
system factors within the human resource and support services component of 
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the conceptual framework of of key components of maternal and newborn 
health care as proposed by Blaauw and Kekana. 
 
Limitations  
The doer and non-doer analysis has made a contribution towards assessing 
whether standardised protocols of management are implemented for ALL 
pregnant women living with HIV.  However, the small sample of clinics available 
for analysis resulted in wide confidence intervals, and an inability to discriminate 
statistically significant associations in the range of health system factors 
assessed.   
 
The cross-sectional study design, relying on data extracted from the BANC 
register, was useful for this pilot study.  A stronger study design, using 
observational, real-time data, could provide greater insights into the TB 
management in clinics of pregnant women living with HIV. 
 
Further research required  
A larger study, drawing on a larger sample of clinics, could begin to test 
hypotheses that arise from this study: for example that supervision and 
mentorship visits, clinical audit, and a tracing system, are positively associated 
with TB screening.  In addition, the association of the organisation of services 
and TB screening practices needs to be explored further.   
 
Recommendations  
It is therefore recommended that there is need for the Ministry of Health to 
invest in strengthening health system activities such as ensuring availability of 
skill mix, training, supervision and mentorship so as to improve quality of care 
provided to pregnant women living with HIV and ensuring healthcare worker 
satisfaction. 
 
 
 
